BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Galindo DC, Banks WA, Rhea EM. The impact of acute rosiglitazone on insulin pharmacokinetics at the blood-brain barrier. Endocrinol Diabetes Metab 2020;3:e00149. [PMID: 32704569 DOI: 10.1002/edm2.149] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Banks WA, Noonan C, Rhea EM. Evidence for an alternative insulin transporter at the blood-brain barrier. Aging Pathobiol Ther 2022;4:100-8. [PMID: 36644126 DOI: 10.31491/apt.2022.12.100] [Reference Citation Analysis]
2 Lua J, Ekanayake K, Fangman M, Doré S. Potential Role of Soluble Toll-like Receptors 2 and 4 as Therapeutic Agents in Stroke and Brain Hemorrhage. Int J Mol Sci 2021;22:9977. [PMID: 34576137 DOI: 10.3390/ijms22189977] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Rhea EM, Banks WA. A historical perspective on the interactions of insulin at the blood-brain barrier. J Neuroendocrinol 2021;33:e12929. [PMID: 33433042 DOI: 10.1111/jne.12929] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]